FOXM1: a new therapeutic target of extramammary Paget disease DOI Creative Commons
Takamichi Ito, Yuka Tanaka,

Yumiko Kaku‐Ito

и другие.

Scientific Reports, Год журнала: 2024, Номер 14(1)

Опубликована: Фев. 19, 2024

Abstract Extramammary Paget disease (EMPD) is a rare skin cancer that primarily affects older individuals predominantly in areas with apocrine sweat glands. Although most early EMPD lesions are indolent, patients metastatic have poor prognosis due to the lack of effective systemic treatment. In this study, we investigated role forkhead box M1 (FOXM1), potent transcription factor, and assessed potential FOXM1 as therapeutic target. Immunohistochemistry 112 primary 17 samples revealed expression increased tumor progression. Patients whom was expressed more than 10% cells had significantly shorter disease-specific survival other ( p = 0.0397). vitro studies using our newly established cell line, KS-EMPD-1, found high FOXM1. Knockdown impaired viability, migration, invasion. Inhibition thiostrepton also reduced viability dose-dependent manner. These findings suggest promising target for EMPD.

Язык: Английский

A novel peptide CP29L, selected from the phage displayed cyclic random heptapeptide library, demonstrates its potent inhibitory effects to liver cancer HCCLM3 cells by targeting FOXM1 DOI

Xinyi Hua,

Kun Xiang,

Anping Liang

и другие.

European Journal of Pharmacology, Год журнала: 2025, Номер unknown, С. 177246 - 177246

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

1

Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system DOI

Hanshu Xie,

Chao Zhang

European Journal of Medicinal Chemistry, Год журнала: 2024, Номер 267, С. 116168 - 116168

Опубликована: Фев. 1, 2024

Язык: Английский

Процитировано

5

Novel 8-Methoxycoumarin-3-Carboxamides with potent anticancer activity against liver cancer via targeting caspase-3/7 and β-tubulin polymerization DOI Creative Commons
Ahmad Alzamami, Eman M. Radwan,

Eman Abo-Elabass

и другие.

BMC Chemistry, Год журнала: 2023, Номер 17(1)

Опубликована: Дек. 2, 2023

In the present study, we explored potential of coumarin-based compounds, known for their potent anticancer properties, by designing and synthesizing a novel category 8-methoxycoumarin-3-carboxamides. Our aim was to investigate antiproliferative activity against liver cancer cells. Toward this, developed versatile synthetic approach produce series 8-methoxycoumarin-3-carboxamide analogues with meticulous structural features. Assessment demonstrated significant inhibitory effects on growth HepG2 cells, widely studied cell line. Among screened compound 5 exhibited most among compounds (IC50 = 0.9 µM), outperforming drug staurosporine 8.4 while showing minimal impact normal The flow cytometric analysis revealed that induces cycle arrest during G1/S phase triggers apoptosis in cells increasing percentage arrested G2/M pre-G1 phases. Annexin V-FITC/PI screening further supported induction without necrosis. Further, ability activate caspase3/7 protein substantially inhibited β-tubulin polymerization Finally, molecular modelling affirmed high binding affinity toward active cavity protein, suggesting its mechanistic involvement. Collectively, our findings highlight therapeutic presented class coumarin analogues, especially 5, as promising candidates development effective anti-hepatocellular carcinoma agents.

Язык: Английский

Процитировано

12

Molecular biomarkers of progression in non-muscle-invasive bladder cancer — beyond conventional risk stratification DOI
Mitchell Olislagers, Florus C. de Jong, Vera C Rutten

и другие.

Nature Reviews Urology, Год журнала: 2024, Номер unknown

Опубликована: Авг. 2, 2024

Язык: Английский

Процитировано

4

EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma DOI Open Access
Muhammad Yasir, Jin‐Young Park, Wanjoo Chun

и другие.

International Journal of Molecular Sciences, Год журнала: 2023, Номер 24(20), С. 15173 - 15173

Опубликована: Окт. 14, 2023

Despite their clonal origins, tumors eventually develop into complex communities made up of phenotypically different cell subpopulations, according to mounting evidence. Tumor cell-intrinsic programming and signals from geographically temporally changing microenvironments both contribute this variability. Furthermore, the mutational load is typically lacking in childhood malignancies adult cancers, they still exhibit high cellular heterogeneity levels largely mediated by epigenetic mechanisms. Ewing sarcomas represent highly aggressive affecting bone soft tissue, primarily afflicting adolescents. Unfortunately, outlook for patients facing relapsed or metastatic disease grim. These are fueled a distinctive fusion event involving an FET protein ETS family transcription factor, with most prevalent being EWS/FLI1. originating common driver mutation, sarcoma cells display significant variations transcriptional activity, within among tumors. Recent research has pinpointed distinct activities as principal source heterogeneity, resulting markedly diverse phenotypes. In review, we aim characterize role EWS/FLI exploring its general mechanism activation elucidating implications tumor heterogeneity. Additionally, delve potential therapeutic opportunities target aberrant context treatment.

Язык: Английский

Процитировано

11

The transcription factor FOXQ1 in cancer DOI Creative Commons
Stefan Koch

Cancer and Metastasis Reviews, Год журнала: 2025, Номер 44(1)

Опубликована: Янв. 8, 2025

Язык: Английский

Процитировано

0

Integrated bioinformatics analysis to explore potential therapeutic targets and drugs for small cell carcinoma of the esophagus DOI Creative Commons

Maofei Zhu,

Yueming Chu,

Qiang Yuan

и другие.

Frontiers in Bioinformatics, Год журнала: 2025, Номер 5

Опубликована: Янв. 28, 2025

Background Small cell carcinoma of the esophagus (SCCE) is a rare form esophageal cancer, which also belongs to category neuroendocrine malignant tumors, with low incidence but high aggressiveness, and very poor prognosis for patients. Currently, there lack unique staging treatment guidelines SCCE. Therefore, deeper understanding therapeutic targets mechanisms underlying its occurrence development great importance early diagnosis, identification potential agents improvement Methods Firstly, dataset SCCE was downloaded from GEO database GEO2R tool employed analysis differentially expressed genes (DEGs). GO KEGG DEGs were carried out by using Bioinformatics OmicStudio tools. Then, up- down-regulated intersected oncogenes tumor suppressor respectively, obtain onco/tumor in The STRING conduct protein-protein interaction (PPI) genes, network further constructed Cytoscape, hub obtained through Cytohubba plugin. In addition, miRDB, miRwalk, Targetscan, OncomiR, starbase, Lncbase used predict miRNAs lncRNAs that regulate ceRNA built based on this. Transcription factor-miRNA co-regulatory analyzed NetworkAnalyst embellished Cytoscape. Finally, drugs may target searched DGIdb ConnectivityMAP, docking verification performed Schrodinger. Results A total 820 upregulated 716 downregulated, these, 54 identified as 85 genes. Seven PPI network, AURKA, BIRC5 , CDK1 EZH2 FOXM1 KLF4 UBE2C . Furthermore, 38 filtered molecular results score AURKA multiple (<6). crizotinib lapatinib CDK1, rucaparib EZH2, lowest energy all results. Conclusion are SCCE, among them, be drugs. Crizotinib, lapatinib, can act above inhibit progression play role.

Язык: Английский

Процитировано

0

FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance DOI Creative Commons
Li Zhang, Fang Wei,

Qihui Sun

и другие.

International Journal of Biological Sciences, Год журнала: 2025, Номер 21(3), С. 1047 - 1064

Опубликована: Янв. 13, 2025

Pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal malignancy with limited treatment options. Investigating novel therapeutic targets and understanding mechanisms of chemoresistance are crucial for improving patient outcomes. This study investigated the role CKS1B in PDAC carcinogenesis, stemness chemoresistance, explores underlying driving its upregulation. The findings may provide insights potential strategies PDAC. Methods: expression was analyzed tissues cell lines, impact on proliferation, migration, apoptosis, chemosensitivity were evaluated by using vitro vivo models, mechanistic connection to transcription factor FOXM1 explored molecular biology methods. Results: significantly upregulated correlated poor survival. promoted inhibited apoptosis. Expression enhanced properties pancreatic cancer. knockdown sensitized cells gemcitabine oxaliplatin. Mechanistically, is transcriptionally regulated FOXM1, establishing FOXM1-CKS1B signaling axis that regulates stemness, drug resistance Conclusions: Our strongly suggest plays critical progression, chemoresistance. Targeting represents promising strategy patients.

Язык: Английский

Процитировано

0

Machine learning identification of a novel vasculogenic mimicry-related signature and FOXM1’s role in promoting vasculogenic mimicry in clear cell renal cell carcinoma DOI Creative Commons
Chao Xu,

Sujing Zhang,

Jingwei Lv

и другие.

Translational Oncology, Год журнала: 2025, Номер 53, С. 102312 - 102312

Опубликована: Фев. 3, 2025

Язык: Английский

Процитировано

0

Thiostrepton suppresses intrahepatic cholangiocarcinoma progression via FOXM1-mediated tumor-associated macrophages reprogramming DOI
Yu Li, Yifan Jiang, Rongliang Tong

и другие.

Translational Oncology, Год журнала: 2025, Номер 54, С. 102327 - 102327

Опубликована: Фев. 21, 2025

Язык: Английский

Процитировано

0